NDC Package 69539-022-30 Deferasirox

Tablet, For Suspension Oral - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
69539-022-30
Package Description:
30 TABLET, FOR SUSPENSION in 1 BOTTLE
Product Code:
Proprietary Name:
Deferasirox
Non-Proprietary Name:
Deferasirox
Substance Name:
Deferasirox
Usage Information:
This medication is used to treat ongoing high levels of iron in the body caused by multiple blood transfusions. It is also used to treat high levels of iron in people with a certain blood disorder who do not require blood transfusions (non-transfusion-dependent thalassemia). It works by binding to iron, allowing the body to pass extra iron out in the stool. Deferasirox belongs to a class of drugs known as iron-chelating agents. Frequent blood transfusions are often needed in certain types of blood diseases (such as sickle cell disease, anemia). Blood transfusions have very helpful benefits, but they can cause the body to hold on to too much iron. The extra iron can build up in the body and cause problems such as heart failure, liver disease, and diabetes. Getting rid of extra iron can decrease the risk of these diseases.
11-Digit NDC Billing Format:
69539002230
NDC to RxNorm Crosswalk:
  • RxCUI: 597768 - deferasirox 125 MG Tablet for Oral Suspension
  • RxCUI: 597770 - deferasirox 250 MG Tablet for Oral Suspension
  • RxCUI: 597772 - deferasirox 500 MG Tablet for Oral Suspension
  • Product Type:
    Human Prescription Drug
    Labeler Name:
    Msn Laboratories Private Limited
    Dosage Form:
    Tablet, For Suspension - A tablet that forms a suspension when placed in a liquid (formerly referred to as a ‘dispersible tablet’).
    Administration Route(s):
  • Oral - Administration to or by way of the mouth.
  • Active Ingredient(s):
    Sample Package:
    No
    FDA Application Number:
    ANDA209878
    Marketing Category:
    ANDA - A product marketed under an approved Abbreviated New Drug Application.
    Start Marketing Date:
    11-20-2019
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Other Product Packages

    The following packages are also available for this product:

    NDC Package CodePackage Description
    69539-022-0610 BLISTER PACK in 1 CARTON / 10 TABLET, FOR SUSPENSION in 1 BLISTER PACK (69539-022-11)
    69539-022-9090 TABLET, FOR SUSPENSION in 1 BOTTLE
    69539-022-991000 TABLET, FOR SUSPENSION in 1 BOTTLE

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 69539-022-30?

    The NDC Packaged Code 69539-022-30 is assigned to a package of 30 tablet, for suspension in 1 bottle of Deferasirox, a human prescription drug labeled by Msn Laboratories Private Limited. The product's dosage form is tablet, for suspension and is administered via oral form.

    Is NDC 69539-022 included in the NDC Directory?

    Yes, Deferasirox with product code 69539-022 is active and included in the NDC Directory. The product was first marketed by Msn Laboratories Private Limited on November 20, 2019 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 69539-022-30?

    The 11-digit format is 69539002230. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-269539-022-305-4-269539-0022-30